JDD Webinars

Recognizing the Role of The Sebaceous Gland in Acne

By October 6, 2020April 22nd, 2021No Comments

Featured Article

Recognizing The Role of the Sebaceous Gland in Acne

The Role of Androgen Receptors in the Development and Management of Acne Vulgaris

Androgen and androgen receptor (AR) may play important roles in several skin related diseases including androgenetic alopecia and acne vulgaris and recent studies suggest AR and androgens play distinct roles in the skin pathogenesis, and AR seems to be a better target than androgens for the treatment of these skin diseases.

Tune in as Leon H. Kircik, MD and James Q. Del Rosso, DO, FAOCD, FAAD discuss the mechanisms by which androgen/AR regulate sebocyte activity in acne vulgaris, and how suppressing AR function by treating with antiandrogens alone, or in combination with antibiotics (i.e., to reduce bacterial infection) might be a potential therapeutic approach to treat acne more effectively.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Faculty


Leon H. Kircik, MD

Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY


James Q. Del Rosso, DO, FAOCD, FAAD

Research Director & Principal Investigator
JDR Dermatology Research
Thomas Dermatology
Las Vegas, Nevada

You May Also Like

Retrospective Review of Dermal Safety Studies of Organic Sunscreens

| Featured Articles, The Latest, Video Abstract | No Comments
Check out our all-new JDD Video Abstract from Joshua Zeichner MD, who discusses Retrospective Review of Dermal Safety Studies of Organic Sunscreens.
Journal of Drugs in Dermatology JDD Article about Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

| Dyspigmentation, Featured Articles, Latest News | No Comments
Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025  article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations…
Journal of Drugs in Dermatology JDD Article about Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

| Derm Community, Featured Articles, Latest News | No Comments
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…

Leave a Reply